Science and Education Publishing
From Scientific Research to Knowledge
Submission
Browse by Subjects
Search
Journal Home
For Authors
Online Submission
Current Issue
Archive
About Us
Figures index
From
Antibodies to
Echinococcus granulosus
Egg Antigens in Hydatid Patients: Characterization by Immunoblot and Diagnostic Value
Wissal IRAQI HOUSSAINI
American Journal of Microbiological Research
.
2015
, 3(1), 33-40 doi:10.12691/ajmr-3-1-5
Fig
ure
1
.
13% SDS-PAGE pattern of
E. granulosus
EA, PA and HCF in non reducing conditions. The position of the molecular weight markers is displayed on the left (Lane 1: EA, Lane 2: PA, Lane 3: HCF)
Full size figure and legend
Fig
ure
2
.
IB reactivity of hyperimmume rabbit antisera to HCF, PA or EA with HCF, PA or EA. The position of the molecular weight markers is displayed on the left. (
A:
Hyperimmume rabbit antisera to HCF,
B:
Hyperimumme rabbit antisera to PA,
C:
Hyperimmune rabbit antisera to EA) (Lane 1: EA, Lane 2: PA., Lane 3: HCF)
Full size figure and legend
Fig
ure
3
.
IB reactivity of moAb specific to Ag 5 with EA, PA and HCF. The molecular weight of the two subunits revealed, is displayed on the right (Lane 1: EA, Lane 2: PA, Lane 3: HCF)
Full size figure and legend
Fig
ure
4
.
IB reactivity to EA of 20 hydatid patient sera. The position of the molecular weight markers is displayed on the left
Full size figure and legend
Fig
ure
5
.
IB reactivity to PA of 20 hydatid patient sera. The position of the molecular weight markers is displayed on the left
Full size figure and legend
Fi
gure
6
.
IB reactivity to HCF antigens of 20 hydatid patient sera. The position of the molecular weight markers is displayed on the left
Full size figure and legend
Fig
ure
7
.
Distribution of individual results obtained in ELISA to EA (a), PA (b) and HCF (c) in 20 sera from patients with CE, 13 sera from healthy controls and 42 sera from subjects with other diseases. Mean absorbance value of the 55 sera controls plus 2 SD was taken as cut off level for positivity (Horizontal line). (Group 1: Patients with CE (n=20); Group 2: Healthy controls (n=13); Group 3: Individuals with ancylostomiasis (n=8); Group 4: Individuals with ascariasis (n=6); Group 5: Persons with hymenolepiasis (n=3); Group 6: Persons with shistosomiasis (n=5); Group 7: Individuals with viral hepatitis B (n=10); Group 8: Individuals with visceral leishmaniasis (n=10))
Full size figure and legend